SenesTech, Inc. (SNES)
0.829
-0.01
(-0.71%)
USD |
NASDAQ |
Oct 06, 16:00
0.83
0.00 (0.00%)
After-Hours: 20:00
SenesTech Enterprise Value : 1.896M for Oct. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 1.896M |
| October 05, 2026 | 1.927M |
| October 02, 2026 | 1.630M |
| October 01, 2026 | 1.052M |
| September 30, 2026 | 1.088M |
| September 29, 2026 | 0.9462M |
| September 28, 2026 | 0.8513M |
| September 25, 2026 | 1.286M |
| September 24, 2026 | 1.349M |
| September 23, 2026 | 1.632M |
| September 22, 2026 | 1.641M |
| September 21, 2026 | 1.770M |
| September 18, 2026 | 1.824M |
| September 17, 2026 | 1.901M |
| September 16, 2026 | 1.853M |
| September 15, 2026 | 2.061M |
| September 14, 2026 | 2.032M |
| September 11, 2026 | 2.063M |
| September 10, 2026 | 2.241M |
| September 09, 2026 | 2.086M |
| September 08, 2026 | 2.219M |
| September 04, 2026 | 2.802M |
| September 03, 2026 | 3.014M |
| September 02, 2026 | 3.121M |
| September 01, 2026 | 3.227M |
| Date | Value |
|---|---|
| August 31, 2026 | 3.121M |
| August 28, 2026 | 3.227M |
| August 27, 2026 | 3.333M |
| August 26, 2026 | 3.651M |
| August 25, 2026 | 3.81M |
| August 24, 2026 | 3.81M |
| August 21, 2026 | 4.181M |
| August 20, 2026 | 4.287M |
| August 19, 2026 | 4.234M |
| August 18, 2026 | 4.340M |
| August 17, 2026 | 3.916M |
| August 14, 2026 | 3.916M |
| August 13, 2026 | 4.155M |
| August 12, 2026 | 4.208M |
| August 11, 2026 | 4.181M |
| August 10, 2026 | 4.234M |
| August 07, 2026 | 4.340M |
| August 06, 2026 | 4.234M |
| August 05, 2026 | 6.144M |
| August 04, 2026 | 6.356M |
| August 03, 2026 | 5.719M |
| July 31, 2026 | 4.659M |
| July 30, 2026 | 4.500M |
| July 29, 2026 | 4.234M |
| July 28, 2026 | 4.606M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Enveric Biosciences, Inc. | -2.510M |
| LENZ Therapeutics, Inc. | -100.36M |
| Impact BioMedical, Inc. | 43.22M |
| ANI Pharmaceuticals, Inc. | 1.878B |
| Corcept Therapeutics, Inc. | 12.61B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.832M |
| Revenue (Quarterly) | 0.77M |
| Total Expenses (Quarterly) | 2.602M |
| EPS Diluted (Quarterly) | -0.3454 |
| Gross Profit Margin (Quarterly) | 69.74% |
| Profit Margin (Quarterly) | -237.9% |
| Earnings Yield | -164.1% |
| Normalized Earnings Yield | -164.15 |